Clinical Study

Perinatal Risks Associated with Early Vanishing Twin Syndrome following Transfer of Cleavage- or Blastocyst-Stage Embryos

Table 5

Low birth weight and multiple logistic regression to account for confounding variables.

LBWStandard errorAdjusted OR
(95% CI)
P

Age (<35 versus ≥35 years)0.591.16 (0.43–3.14)0.77
Duration of ovarian stimulation (<9 versus ≥9 days)1.251.24 (0.17–8.96)0.83
Gonadotropin dose (<2000 versus ≥2000 IU)0.760.81 (0.13–5.04)0.82
Peak E2 level (<2000 versus ≥2000 pg/Ml)0.300.86 (0.44–1.69)0.66
Total number of oocytes (<10 versus ≥10)0.200.93 (0.18–4.13)0.77
Blastocyst-stage ET (yes versus no)0.110.85 (0.66–1.99)0.20

LBW: low birth weight; E2: estradiol; ET: embryo transfer.